Copy to clipboard 
MediView XR received FDA 510(k) clearance to market the XR90 augmented reality-based surgical visualization and navigation platform. XR90 is intended to be used adjunctively for minimally invasive ultrasound and CT-guided needle-based procedures for soft tissue and bone. This is reportedly the first 510(k) clearance for an augmented reality device utilizing live imaging combined with 3D XR visualization for pre- and intra-operative indications for use.
MediView uses augmented reality to address the limitations of current medical imaging technologies. Flat panel monitors limit practitioners to 2D imaging and require them to look away from the patient’s procedural site, disrupting hand/eye coordination, resulting in reduced clinician confidence and potentially impacting outcomes.
Through Microsoft’s HoloLens 2 AR headset, clinicians can visualize the patient’s ultrasound, as well as displays of other procedural information to facilitate their workflow. XR90 provides physicians with 3D “X-Ray vision” during procedures, projecting 3D virtual models of the patient’s own anatomy based on their CT imaging. XR90’s augmented reality capabilities include a Holographic Light Ray that tracks and displays the path of the physician’s instrument, CT-based 3D holographic anatomy display, and live ultrasound that is projected and displayed anatomically into the patient as the clinician scans, similar to a flashlight beam. The system is designed to provide visual information and reference to clinicians for analysis of procedural options during pre-operative planning, to help facilitate workflow, and to provide enhanced ergonomics to the user for heads-up, intra-operative display of medical images during ultrasound-guided needle procedures. XR90 is indicated to be used adjunctively to standard of care imaging.
Clinicians at remote locations can also collaborate real-time with shared visualization, communication and the ability to provide guidance during procedures for collaborative patient care. These features can provide increased support for understaffed facilities, rural or underserved populations and a distinct ability to limit caregiver and patient exposure to COVID-19 while maintaining care levels.
Recently, MediView secured a $15 million strategic funding round with backing from leading collaborators including Mayo Clinic, Cleveland Clinic, GE HealthCare, etc.
Mina Fahim, President and CEO of MediView, said, “XR90 expands the MediView portfolio of solutions available to practitioners as they look to simplify, democratize, and inform care delivery with the ultimate goal of improving and expanding access to the best care.”
Source: MediView
MediView XR received FDA 510(k) clearance to market the XR90 augmented reality-based surgical visualization and navigation platform. XR90 is intended to be used adjunctively for minimally invasive ultrasound and CT-guided needle-based procedures for soft tissue and bone. This is reportedly the first 510(k) clearance for an augmented reality...
MediView XR received FDA 510(k) clearance to market the XR90 augmented reality-based surgical visualization and navigation platform. XR90 is intended to be used adjunctively for minimally invasive ultrasound and CT-guided needle-based procedures for soft tissue and bone. This is reportedly the first 510(k) clearance for an augmented reality device utilizing live imaging combined with 3D XR visualization for pre- and intra-operative indications for use.
MediView uses augmented reality to address the limitations of current medical imaging technologies. Flat panel monitors limit practitioners to 2D imaging and require them to look away from the patient’s procedural site, disrupting hand/eye coordination, resulting in reduced clinician confidence and potentially impacting outcomes.
Through Microsoft’s HoloLens 2 AR headset, clinicians can visualize the patient’s ultrasound, as well as displays of other procedural information to facilitate their workflow. XR90 provides physicians with 3D “X-Ray vision” during procedures, projecting 3D virtual models of the patient’s own anatomy based on their CT imaging. XR90’s augmented reality capabilities include a Holographic Light Ray that tracks and displays the path of the physician’s instrument, CT-based 3D holographic anatomy display, and live ultrasound that is projected and displayed anatomically into the patient as the clinician scans, similar to a flashlight beam. The system is designed to provide visual information and reference to clinicians for analysis of procedural options during pre-operative planning, to help facilitate workflow, and to provide enhanced ergonomics to the user for heads-up, intra-operative display of medical images during ultrasound-guided needle procedures. XR90 is indicated to be used adjunctively to standard of care imaging.
Clinicians at remote locations can also collaborate real-time with shared visualization, communication and the ability to provide guidance during procedures for collaborative patient care. These features can provide increased support for understaffed facilities, rural or underserved populations and a distinct ability to limit caregiver and patient exposure to COVID-19 while maintaining care levels.
Recently, MediView secured a $15 million strategic funding round with backing from leading collaborators including Mayo Clinic, Cleveland Clinic, GE HealthCare, etc.
Mina Fahim, President and CEO of MediView, said, “XR90 expands the MediView portfolio of solutions available to practitioners as they look to simplify, democratize, and inform care delivery with the ultimate goal of improving and expanding access to the best care.”
Source: MediView
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
